In situ immunostainings on paraffin-embedded tumor sections revealed that the angiogenic markers CD31 and smooth muscle actin (SMA), increased by HFHCD, were normalized to the CD level, when switching HFHCD to CD (Fig. 6f–i). Here, SMN1 is linked to neoplasm.